Archive for the ‘Marketing’ Category
Regardless of your views on certain social media accounts and posts, there’s no denying the influence that Twitter, Facebook, and other platforms have on the public. So why not embrace these social networks to spread knowledge? Those in the life sciences understand the importance of disease awareness, so adding social media into the equation is a clear path for the industry.
Posts from professionals, patients, and more can sway the public’s knowledge about diseases and what those diseases entail. Also, just as social media has influenced opinions and changed minds, taboo ailments (i.e., mental illness, HIV,…
Content marketing is one of the most effective tools life science professionals have in their arsenal. Developing an effective campaign, however, can be difficult. We’ve put together these simple tips to help guide you in the right direction.
Tip #1: Know Your Audience.
Before you start creating content, be sure you know the answer to this simple question: Who are you trying to reach? Keeping your target audience in mind as you create content can be the difference between a successful campaign and one that falls short. For instance,…
This guest blog post is a continuation of last week’s PR Experts Shed Light On… (Part One) article. Dave Hochman, owner of the Red Bank, NJ-based DJH Marketing Communications, Inc., spoke to faculty members from the 11th Public Relations & Communications Summit about the opportunities and challenges pharma PR professionals face.
To learn more about Dave, visit www.djhmarcom.com, email him at firstname.lastname@example.org or follow him on Twitter @davehochman.
Q: What can other industries look to pharma for right now in terms of ideas and inspiration beyond endorsements and collaborations…
This guest blog post is written by Dave Hochman, and is part one of an interview Dave performed following the 11th Public Relations & Communications Summit in July 2015.
Dave is the owner of the Red Bank, NJ-based DJH Marketing Communications, Inc. To learn more about Dave, visit www.djhmarcom.com, email him at email@example.com or follow him on Twitter @davehochman.
After the 11th Public Relations & Communications Summit took place in July, we were fortunate enough to be able to circle back with some of the…
The changing nature of the relationship between life science companies and their clients is a hot topic that comes up at our events. We recently had the pleasure of reading Results: The Future of Pharmaceutical and Healthcare Marketing, a new book about the top trends shaping how healthcare and pharma companies approach marketing in today’s rapidly evolving world, and jumped at the opportunity to interview its authors. Here’s what they had to say in response to our questions.
What were the primary catalysts that spurred you to write Results?
With more than 140 industry marketers, sales professionals and thought leaders in attendance at the 5th Digital Marketing for Medical Devices conference, this three-day event was a resounding success. The speakers were insightful and engaging, and delegates returned to work armed with best practices and new strategies to try in their workplaces — but don’t just take our word for it. These recaps will give you a glimpse of what you may have missed if you were unable to come to this event.
Words of Wisdom from Prolifiq and App Data…
This guest blog post is written by Dave Hochman. Dave is the owner of the Red Bank, NJ-based DJH Marketing Communications, Inc. For more information, go to www.djhmarcom.com, email firstname.lastname@example.org or follow Dave on Twitter @davehochman.
One of the first day’s speakers at Exl Pharma’s 11th Public Relations & Communications Summit at Sanofi US in July was Peter Shankman, a PR industry pundit and the author of such books as “Zombie Loyalists: Using Great Service to Create…
Healthcare reform has been a major topic in America the last few years. Everyone wants to see the cost of staying healthy go down, or at least become affordable. The problem is those costs consist of several different factors. Getting control of expenses becomes difficult when one factor’s price rises. Such is the case with the increasing costs of prescription drugs.
Rising costs imperil the goal of maintaining good health and create the potential for greater costs in the long run. The obstacles presented by the inability…
When the 11th Annual Public Relations & Communications Summit took place in July, more than 150 PR and comm professionals joined ExL Pharma at Sanofi’s New Jersey headquarters to participate in one of our favorite conferences of the year. We love engaging with our audience and hearing their thoughts, and are excited to share coverage of the event through their eyes with you.
What Attendees Had to Say
On the Makovsky Health blog, Group Vice President Rob Murphy discussed the importance of meaningful connections and value-added interactions….
Recent studies show that leading life science companies have drastically improved their technology in order to enhance their product marketing, and it’s a no-brainer why they are doing this. Having the ability to choose which targeted audience you want your product to reach is becoming increasingly important, but how can you escalate exposure while cutting costs? Get with the programmatic!
Programmatic strategies can identify which customers you want to advertise to the quickest, and this customization can save your organization…
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs